Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
We outline common circumstances where index funds may be preferable to ETFs, including buy-and-hold strategies and simplicity.
25,141 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Rising tensions around Iran push energy costs higher and complicate the macro outlook. Analysts warn that stagflation...
Pi Network leads a crypto rally with a five-month peak as Kraken enables PI trading and XRP signals potential breakou...
Cal-Maine Foods is navigating a turning point: a fading egg-price super-cycle and a strategic push into specialty egg...
Since 2020, five magnificent stocks have split their shares. Only Alphabet and Tesla outpaced the market, proving tha...
A notable AI stock has fallen about 30% this year. This article lays out a practical, battle-tested framework to judg...
In a volatile economy, boards are adjusting performance targets to preserve executive compensation. This piece explai...
Tech Mahindra's Mohit Joshi says AI will transform jobs, not vanish them. This piece surveys how IT services leaders ...
Oracle is sitting on a massive backlog that could redefine its AI trajectory in 2026. This deep dive breaks down what...
A short-seller report rattled SoFi stock, but headlines don’t always tell the full story. This analysis digs into the...
Boeing, Honeywell, and 3M all fell in after-hours trading as Q4 results rolled out, signaling divergent paths. This p...
Bank of America upgrades Oracle to Buy, signaling potential upside as AI-driven cloud demand and a massive backlog cr...